Beta-lactam antibiotics in combination with novel β-lactamase inhibitors – an alternative therapy for infections caused by multidrug-resistant bacteria Cover

.blurhash-client-img { display: none !important; }

Beta-lactam antibiotics in combination with novel β-lactamase inhibitors – an alternative therapy for infections caused by multidrug-resistant bacteria

Pomeranian Journal of Life Sciences

Volume 70 (2024): Issue 1 (March 2024)

By: Małgorzata Brauncajs , Filip Bielec , Anna Macieja and Dorota Pastuszak-Lewandoska

Open Access

|Apr 2024

Metrics

DOI: https://doi.org/10.21164/pomjlifesci.973 | Journal eISSN: 2719-6313 | Journal ISSN: 2450-4637

Journal RSS Feed

Language: English

Page range: 7 - 14

Published on: Apr 25, 2024

Published by: Pomeranian Medical University

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

antimicrobials,

meropenem/vaborbactam,

imipenem/relebactam,

ceftazidime/avibactam,

multi-drug resistance,

antimicrobial susceptibility testing,

Related subjects:

Basic medical science,

Basic medical science, other,

Clinical medicine,

Surgery, other,

© 2024 Małgorzata Brauncajs, Filip Bielec, Anna Macieja, Dorota Pastuszak-Lewandoska, published by Pomeranian Medical University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 70 (2024): Issue 1 (March 2024)Next article